coinpedia Sep 01, 2026

VeChain Price Faces Key Test as VIP-255 Nears Launch

The post VeChain Price Faces Key Test as VIP-255 Nears Launch appeared first on Coinpedia Fintech News The VeChain price has reach...

decrypt Sep 01, 2026

Cathie Wood’s Ark Invest Buys $37 Million in Bitcoin and Payments Firm Block

The investment firm bought 456,059 Block shares across three ETFs and added $3.4 million in Circle stock.

cointelegraph Sep 01, 2026

Ethena launches USDe payments app, offers 6% rewards

The self-custodial app brings USDe into everyday payments, savings and cross-border transfers, with annualized rewards of up to 6%...

blockonomi Sep 01, 2026

Navitas Semiconductor (NVTS) Stock: First Gen 5 GaNFast Wafers Set for September

TLDR Navitas sets September shipments for its first U.S.-made Gen 5 GaNFast wafers GlobalFoundries partnership brings Navitas Gen...

coinpedia Sep 01, 2026

Chainlink Price Eyes $18 as Exchange Supply Falls

The post Chainlink Price Eyes $18 as Exchange Supply Falls appeared first on Coinpedia Fintech News Chainlink price is heading int...

blockonomi Sep 01, 2026

LSE Partners With Kraken’s Parent Company to Launch Tokenized UK Equities

London Stock Exchange partners with Kraken parent Payward to tokenize 100 UK stocks via xStocks, offering 24/7 trading access to g...

blockonomi Sep 01, 2026

Intuitive Machines, Inc. (LUNR) Stock: New IM 300 Contract Expands Spacecraft Cu...

TLDR Intuitive Machines wins a new contract for two IM 300 spacecraft platforms. New IM 300 order expands Intuitive Machines into...

blockonomi Sep 01, 2026

Yum! Brands (YUM) Stock Slides as Pizza Hut Sale to LongRange Capital Finalizes

Yum! Brands (YUM) shares fell 0.68% as LongRange Capital finalized its Pizza Hut acquisition. Eduardo Luz named Interim CEO. Deal...

blockonomi Sep 01, 2026

Piper Sandler Boosts Tempus AI (TEM) Stock Rating to Overweight with $76 Target

Tempus AI (TEM) stock rose 2% after Piper Sandler upgraded it to Overweight with a $76 target, citing Personalis deal and FDA appr...

blockonomi Sep 01, 2026

Alumis (ALMS) Stock Crashes Over 50% Following Lupus Trial Disappointment

Alumis (ALMS) stock plummeted 56% after Phase 2b lupus trial failure. IFNGS-high subgroup showed promise. Psoriasis NDA filing sti...